
‘See The Savings’: Guwahati Jan Aushadhi Kendra Shows Medicine Price Gaps With Market Rates
Heavy footfall has been reported at Jan Aushadhi Kendras across Guwahati. Beneficiaries say the scheme has brought a remarkable change in their lives, as essential medicines are now available at 50–70 per cent lower prices compared to regular pharmacies.
Many said the initiative is especially beneficial for those from economically weaker sections. A standout feature of the Jan Aushadhi Kendra in Guwahati is the prominently displayed rate comparison list, which shows the prices of medicines sold at the Kendra alongside their prices at regular pharmacies-enabling customers to clearly see the savings and make informed choices.
Bilaluddin, one of the beneficiaries, told IANS: "We get medicines at much cheaper rates from the Jan Aushadhi Kendra. At regular pharmacies, we had to pay a lot more. The low prices here help us immensely. This is a great scheme by PM Modi, and I want to thank him for this."
Another customer shared similar sentiments, saying: "The government's scheme is helping people a lot. Patients are getting quality medicines at affordable rates. Everyone is benefiting. I urge people to buy medicines from here. The quality is excellent."
The store operator also confirmed that the response from customers has been overwhelming.
"There is a steady rush of customers at our store. Medicines here are 50–90 per cent cheaper than other pharmacies. There's no compromise on quality; all drugs are tested in laboratories before reaching the shelves. Customers find them effective, and we're thankful to PM Modi for launching such a helpful scheme. Medicines worth Rs 2,000 elsewhere are available here for Rs 500–700, clearly benefiting the poor."
The Jan Aushadhi Scheme, which aims to provide generic medicines at affordable rates, is proving to be a game-changer in ensuring healthcare equity in urban and semi-urban areas like Guwahati.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Moonx: Bydfi's On-Chain Trading Engine - A Ticket From CEX To DEX
- Uptech Wins Best Risk Management Solutions Provider UAE And Best Trading Technology Provider UAE Awards 2025
- AR.IO Launches Credit Card Payments For Web3 Identity And Hosting On Arweave
- Signalrank Marks Two-Year Milestone With Strong Performance, Announces V4 Of Investment Selection Model
- Alpine Funded Celebrates First Anniversary With Major Milestone And Global Growth
- User Growth Surges Across Biomatrix Ecosystem After Ipoy Debut
Comments
No comment